Recurrent tumefactive demyelination without evidence of multiple sclerosis or brain tumour

Journal of Neurology

Volumn 258, Issue 2, 2011, Pages 318-320

  Hane A ^a   Bargetzi, M ^a   Hewer, E ^a   Bruehlmeier, M ^a   Khamis, A ^a   Roelcke, U ^a  

^a CANTONAL HOSPITAL AARAU   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYGLUCOSE; DEXAMETHASONE;

AGED; AUTOPSY; BONE MARROW EXAMINATION; BRAIN BIOPSY; BRAIN TUMOR; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CONFUSION; CONTRAST ENHANCEMENT; DEMYELINATION; DIFFERENTIAL DIAGNOSIS; FLUORESCENCE ACTIVATED CELL SORTING; HEADACHE; HEART ATRIUM FIBRILLATION; HEMATURIA; HEMINEGLECT; HUMAN; HUMAN TISSUE; ISCHEMIC HEART DISEASE; KIDNEY CARCINOMA; LETTER; MALE; MULTIPLE SCLEROSIS; MYELODYSPLASTIC SYNDROME; NEGLECT; NUCLEAR MAGNETIC RESONANCE IMAGING; PLEOCYTOSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TUMEFACTIVE DEMYELINATION; TUMOR RECURRENCE;

AGED; ANTI-INFLAMMATORY AGENTS; ATRIAL FIBRILLATION; BRAIN DISEASES; BRAIN NEOPLASMS; CARCINOMA, RENAL CELL; CORONARY DISEASE; DEMYELINATING DISEASES; DEXAMETHASONE; DIAGNOSIS, DIFFERENTIAL; HUMANS; KIDNEY NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS; MYELODYSPLASTIC SYNDROMES; RECURRENCE;

EID: 79953772487     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-010-5722-1     Document Type: Letter

References (10)

1. Lucchinetti CF, Gavrilova RH, Metz I et al (2008) Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain 131:1759-1775 (Pubitemid 351957454)
2. Ng S, Butzkueven H, Kalnins R et al (2007) Prolonged interval between sentinel pseudotumoral demyelination and development of primary CNS lymphoma. J Clin Neurosci 14:1126-1129 (Pubitemid 47588932)
3. Kim DS, Na DG, Kim KH et al (2009) Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: added value of unenhanced CT compared with conventional contrast-enhancedMRimaging. Radiology 251:467-475
4. Jain R, Ellika S, Lehmann NL et al (2010) Can permeability measurements add to blood volume measurements in differentiating tumefactive demyelinating lesions from high grade gliomas using perfusion CT? J Neurooncol 97:383-388
5. Kepes JJ (1993) Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients. Ann Neurol 33:18-27
6. Sloand EM, Rezvani K (2008) The role of the immune system in myelodysplasia: implications for therapy. Semin Hematol 45:39-48
7. Derweesh IH, Tannenbaum CS, Rayman PA et al (2003) Mechanisms of immune dysfunction in renal cell carcinoma. Cancer Treat Res 116:29-51
8. Xia L, Lin S, Wang ZC et al (2009) Tumefactive demyelinating lesions: nine cases and a review of the literature. Neurosurg Rev 32:171-179
9. Nadkar MY, Deore RA, Singh R (2008) Tumefactive demyelination. J Assoc Physicians India 56:901-903
10. Mao-Draayer Y, Braff S, Pendlebury W et al (2002) Treatment of steroid-unresponsive tumefactive demyelinating disease with plasma exchange. Neurology 59:1074-1077